SCHEMBL13435002

SCHEMBL13435002

C=CCC(CC1CCC1)C(=O)NC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 1/20 0.37
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LTA4H P09960 1/20 0.34
CTSS P25774 2/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
MMP1 P03956 5/20 0.32
MMP13 P45452 2/20 0.32
CTSK P43235 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
ATM Q13315 1/20 0.32
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
METAP2 P50579 1/20 0.31
REN P00797 1/20 0.31
THRA P10827 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13435000 0.97 CPB2 (0.40) CPB2KMT2AALDH1A1LTA4HCTSS
SCHEMBL13435001 0.94 THRA (0.35) CPB2KMT2AALDH1A1LTA4HCTSS
SCHEMBL13435011 0.84 CPB2 (0.37) CPB2KMT2AALDH1A1LTA4HCTSS
SCHEMBL13500184 0.83 MMP1 (0.36) KMT2AALDH1A1LTA4HMMP1MMP13
SCHEMBL13434984 0.83 CPB2 (0.41) CPB2KMT2AALDH1A1LTA4HCTSS
SCHEMBL13499674 0.82 LTA4H (0.44) KMT2AALDH1A1LTA4HTSHRMMP1
SCHEMBL13435008 0.81 CPB2 (0.39) CPB2KMT2AALDH1A1LTA4HCTSS
SCHEMBL14117540 0.81 CPB2 (0.37) CPB2KMT2AALDH1A1CTSSMMP1
SCHEMBL8241409 0.81 CPB2 (0.37) CPB2KMT2AALDH1A1CTSSMMP1
SCHEMBL14375683 0.81 CPB2 (0.37) CPB2KMT2AALDH1A1CTSSMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069373-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2010-03-18 US disclosed
US-20100056501-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2010-03-04 US disclosed
US-20100048541-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2010-02-25 US disclosed
US-20090170831-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2009-07-02 US disclosed
US-7498324-B2 Substituted lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2009-03-03 US disclosed
US-20080221087-A1 Substituted lactams as inhibitors of abeta protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-09-11 US disclosed
US-7390802-B2 Substituted lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA CORPORATION (US) 2008-06-24 US disclosed
US-7276495-B2 Substituted lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-10-02 US disclosed
US-7276495-B2 Substituted lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-10-02 US disclosed
US-20070173491-A1 Substituted lactams as inhibitors of Abeta protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221087-A1 Substituted lactams as inhibitors of abeta protein production BACE1, APP, APH1A CPB2 302/4885KMT2A 4379/4885ALDH1A1 3896/4885
US-20100048541-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BACE1, APP, APH1A CPB2 302/4885KMT2A 4379/4885ALDH1A1 3896/4885
US-20090170831-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BACE1, APP, APH1A CPB2 415/4885KMT2A 4026/4885ALDH1A1 3909/4885
US-20070173491-A1 Substituted lactams as inhibitors of Abeta protein production BACE1, APP, APH1A CPB2 302/4885KMT2A 4379/4885ALDH1A1 3896/4885
US-20100069373-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION BACE1, APP, BACE2 CPB2 326/4885KMT2A 4222/4885ALDH1A1 3509/4885
US-20100056501-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BACE1, APP, APH1A CPB2 302/4885KMT2A 4379/4885ALDH1A1 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.